Stem Cell Conferences, Stem Cell Congress, Stem cell Convention,Worlds best stem cell conferences, Conference discounts,Stem Cell Convention 2017, Stem Cell Asia Pacific, cord blood stem cell Conferences, Regenerative Medicine Conferences

Previous Speakers

Raphael Gorodetsky

Hadassah-Hebrew University Medical Center Israel

Taihua Wang

Interventional Hospital of Shandong Red Cross Society China

Y James Kang

Sichuan University China

Pierre-Edouard Dolle

Universite Catholique de Louvain Belgium

Prabhu Mishra

Stemgenn Therapeutics and secretary general-stem cell society India

Aditya Borakati

University of Hull UK

Gang Zhang

Interventional Hospital of Shandong Red Cross Society and Cell Biotechnology Co. Ltd. China

Naglaa Kamal Idriss

Assiut University,University of Southampton, UK Egypt

Recommended Global Genetics & Molecular Biology Webinars & Conferences

Europe & UK

Stem Cell 2025, Germany cellscience-cs-2025, Spain Human Genetics 2025, Spain Genome 2025, Spain

Asia Pacific & Middle East

Biobanking 2017, USA

Canada

Stem Cell Convention-2017

Sessions/Tracks

Conference Series Ltd invites all the members of Biological Sciences family, from all over the world to join and share research at the “10th World Congress on Stem Cell and Biobanking” during 23th & 24th October, 2017 at Osaka, Japan, which includes prompt keynote presentations, plenary talks, oral talks, poster presentations and exhibitions.

Theme: “Accelerating the Innovative Research &Technology in Stem Cell & Biobanking”

Stem Cell Convention 2017 aims in proclaim knowledge and share new ideas amongest the professionals, industrialists and students from research area of Stem Cells and Biobanking to share their research experiences and indulge in interactive discussions at the event. This scientific gathering guarantees that offering the thoughts and ideas will enable and secure you the theme “Accelerating the Innovative Research &Technology in Stem Cell & Biobanking”. Biobanking is the latest trending technology in many fields. The current era fully rolled out with many new Stem cells and Biobanking technologies. In such case more research centres and Hospitals were newly introduced within market which obviously shows the market growth of stem cells and Biobanking techniques. While analyzing the revenue growth of stem cells research, it highly developed from $150 billion USD to $250 billion USD since from 2010-2015. And the annual growth percentage increases from 20-55 percentages.

Track-1

Stem Cells

An undifferentiated cell of a multicellular creature which is fit for offering ascend to inconclusively more cells of the same sort, and from which certain different sorts of cell emerge by separation. The most entrenched and generally utilized undifferentiated organism treatment is the transplantation of blood foundational microorganisms to treat infections and states of the blood and invulnerable framework, or to restore the blood framework after medications for particular growths. Subsequent to the 1970s, skin undifferentiated organisms have been utilized to develop skin joins for patients with serious smolders on expansive territories of the body. Just a couple of clinical focuses can do this treatment and it is normally held for patients with life-debilitating blazes.

Track-2

Stem Cell Therapy

Stem cell therapy is used to treat or prevent diseases by using stem cells. It has potential in a wide range of territories of potential and restorative examination. This treatment is by and large used to supplant or repair harmed cells or tissues. It additionally helps in transplanting immature microorganisms or giving medications those objective undifferentiated organisms as of now in the body. Undeveloped cell treatment is a rising innovation; the recovery of body part is not really another idea.

Track-3

Stem Cell Apoptosis and Signal Transduction

Self-reestablishment and multiplication of foundational microorganism populaces is controlled, to some degree, by affectation of apoptosis. The quantity of foundational microorganisms is thusly a harmony between those lost to separation/apoptosis and those increased through multiplication. Apoptosis of immature microorganisms is accepted to be a dynamic procedure which changes because of natural conditions.

Track-4

Stem Cell Transplantation

Stem cell transplantation, sometimes referred to as bone marrow transplant, is a procedure that replaces unhealthy blood-forming cells with healthy cells. Stem cell transplants commonly are used to treat Leukemia and lymphoma, cancers that affect the blood and lymphatic system.

Track-5

Cell Signalling in Development

Cell signaling mediated by morphogens is essential to coordinate growth and patterning, two key processes that govern the formation of a complex multi-cellular organism. During growth and patterning, cells are specified by both quantitative and directional information. While quantitative information regulates cell proliferation and differentiation, directional information is conveyed in the form of cell polarities instructed by local and global cues.

Trcak-6

Epigenetics

Epigenetics is the study of potentially heritable changes in gene expression (active versus inactive genes) that does not involve changes to the underlying DNA sequence — a change in phenotype without a change in genotype — which in turn affects how cells read the genes. Epigenetic change is a regular and natural occurrence but can also be influenced by several factors including age, the environment/lifestyle, and disease state. Epigenetic modifications can manifest as commonly as the manner in which cells terminally differentiate to end up as skin cells, liver cells, brain cells, etc. Or, epigenetic change can have more damaging effects that can result in diseases like cancer.

Track-7

Stem Cell Embryology

Embryonic stem (ES) cells are cells derived from the early embryo that can be propagated indefinitely in the primitive undifferentiated state while remaining pluripotent; they share these properties with embryonic germ (EG) cells. Candidate Embryonic stem and embryonic germ cell lines from the human blastocyst and embryonic gonad can differentiate into multiple types of cell.

Track-8

Stem Cell Niches

Stem-cell niche refers to a microenvironment, within the specific anatomic location where stem cells are found, which interacts with stem cells to regulate cell fate. The word 'niche' can be in reference to the in vivo or in vitro stem-cell microenvironment. During embryonic development, various niche factors act on embryonic stem cells to alter gene expression, and induce their proliferation or differentiation for the development of the fetus.

Track-9

Stem cell treatment

The most entrenched and broadly utilized undifferentiated organism treatment is the transplantation of blood foundational microorganisms to treat illnesses and states of the blood and invulnerable framework, or to restore the blood framework after medicines for particular malignancies. Subsequent to the 1970s, skin undifferentiated organisms have been utilized to develop skin unites for patients with extreme blazes on substantial territories of the body.

Track-10

Stem Cells Biology

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. They are found in multicellular organisms. In mammals, there are two broad types of stem cells: embryonic stem cells, which are isolated from the inner cell mass of blastocysts, and adult stem cells, which are found in various tissues. In adult organisms, stem cells and progenitor cells act as a repair system for the body, replenishing adult tissues.

Track-11

Stem Cells Technology

Stem cells technology is a rapidly developing field that combines the efforts of cell biologists, geneticists, and clinicians and offers hope of effective treatment for a variety of malignant and non-malignant diseases. Stem cells are defined as totipotent progenitor cells capable of self-renewal and multiline age differentiation. Stem Cell s technology survives well and show stable division in culture, making them ideal targets for in vitro manipulation. Although early research has focused on hematopoietic stem cells, stem cells have also been recognised in other sites. Research into solid tissue stem cells has not made the same progress as that on hematopoietic stem cells. This is due to the difficulty of reproducing the necessary and precise three dimensional arrangements and tight cell-cell and cell-extracellular matrix interactions that exist in solid organs.

Track-12

Stem cell Bioinformatics

The sequencing of the human genome, completed at the dawn of the twenty-first century, allows researchers to integrate new data on genetic risk factors with demographic and lifestyle data collected via modern communication technologies. The technical prerequisites now exist for merging these cascades of molecular genetic information, not only to national health registers, but also to epidemiology and clinical data. Long-term storage of biological materials and data is a critical component of any epidemiological or clinical study. In designing Bio banks, informatics plays a vital role for the handling of samples and data in a timely fashion.

Track-13

Bio-banks

Bio banks play a crucial role in biomedical research. The wide array of bio specimens (including blood, saliva, plasma, and purified DNA) maintained in bio banks can be described as libraries of the human organism. They are carefully characterized to determine the general and unique features of the continuous cell line and the absence or presence of contaminants, therefore establishing a fundamental understanding about the raw material from which the biological product is being derived and maintained. Bio banks catalog specimens using genetic and other traits, such as age, gender, blood type, and ethnicity. Some samples are also categorized according to environmental factors, such as whether the donor had been exposed to radiation, asbestos, or some other substance that can affect human genes. In Bio bank Category the most popular bio bank projects includes cord blood banking, banking stem cells, baby cord blood banking.

Track-14

Stem cells Biomarkers

Bio marker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A bio marker may be used to see how well the body responds to a treatment for a disease or condition.

In cancer research and medicine, bio markers are used in three primary ways:

To help diagnose conditions, as in the case of identifying early stage cancers (Diagnostic)
To forecast how aggressive a condition is, as in the case of determining a patient's ability to fare in the absence of treatment (Prognostic)
To predict how well a patient will respond to treatment (Predictive).

Track-15

Cells & Organ Regeneration

Regeneration means the regrowth of a damaged or missing organ part from the remaining tissue. As adults, humans can regenerate some organs, such as the liver. If part of the liver is lost by disease or injury, the liver grows back to its original size, though not its original shape. And our skin is constantly being renewed and repaired. Unfortunately many other human tissues don’t regenerate, and a goal in regenerative medicine is to find ways to kick-start tissue regeneration in the body, or to engineer replacement tissues.

Track-16

Biorepository & Biospecimen

A Biorepository is a biological materials repository that collects, processes, stores, and distributes bio specimens to support future scientific investigation. Biorepositories can contain or manage specimens from animals, including humans, and many other living organisms. Vertebrates, invertebrates, arthropods, and other life-forms are just a few of the many classes of living organisms which can be studied by preserving and storing samples taken. The Biorepository assures the quality, and manages the accessibility and distribution/disposition of the bio specimens in its collection. There are a huge number of bio repositories in the United States, which shift broadly by size, the sort of bio specimen gathered, and reason. One of the bio repository's most elevated needs is ensuring the security and sacredness of individual and medicinal data. Bio specimens are materials taken from the human body, for example, tissue, blood, plasma, and pee that can be utilized for growth determination and investigation. At the point when patients have a biopsy, surgery, or other methodology, regularly a little measure of the example evacuated can be put away and utilized for later research. Once these specimens have been legitimately prepared and put away they are known as human bio specimens.

Track-17

Fertility bio banks

Fertility preservation is the effort to help cancer patients retain their fertility, or ability to procreate. Research into how cancer affects reproductive health and preservation options are growing, sparked in part by the increase in the survival rate of cancer patients. The main methods of fertility preservation are ovarian protection by GnRH agonists, cryopreservation of ovarian tissue, eggs or sperm, or of embryos after in vitro fertilization. The patient may also choose to use egg or sperm from a donor by third party reproduction rather than having biological children.

Track-18

Bio bank Ethics

Ethical issues are commonly present in many aspects of Biobanking. The fact that Bio banks deal with human samples, invading an individual autonomy or limiting self-control, provokes a number of ethical issues. Who is actually competent to give informed consent and donate a sample? When individuals donate part of their body to a bio bank, how is that human sample processed? Who is the owner of the sample? Who should decide how it should be used? Who has the right to know individual results of research? These and many more ethical dilemmas exist in the ethical framework of bio banks. With the recent rapid developments in Biobanking, all of these issues are magnified with plenty of further new questions continuously arising. Ethical framework has been the most controversial issue in the domain of bio banking. Thus, it is not surprising that there is a substantial literature focusing on ethical dilemmas in bio banking, such as informed consent, privacy, protection, and returning of results to participants. For many years, researchers at CRB have provided constructive advice on how to deal with ethical aspects of research using human tissue material and personal data. For more than 80 years tissue has been derived from human bodies, stored, distributed and used for therapeutic, educational, forensic and research purposes as part of healthcare routine in most western countries.

American Society for Bioethics and Humanities Houston, USA, Association of Bioethics World Congress Edinburgh, UK, Oxford Global Health and Bioethics International Conference Oxford shire, UK, CFP: Global Forum on Bioethics in Research Foundation Merieux, France, Hands On Bio banks 2016 conference Vienna, Austria, Global Biobanking London, UK, The Biomarker Conference Orlando, Florida – USA, ART World Congress Symposium on Safe and Efficient IVF New York City, United States, VIII International Postharvest Symposium: Enhancing Supply Chain and Consumer Benefits - Ethical and Technological Issues Cartagena, Murcia, Spain.

Track-19

Next Generation Biobanking

Biorepositories provide a resource for researchers to increase understanding of complex diseases. Studies such as the Lung Genomics Research Consortium (LGRC), a two-year project launched in October 2009, are going a step further than standard bio banking practices and characterizing the samples with their molecular makeup. The molecular data can then be mined along with the clinical data. Led by National Jewish Health and funded by the National Heart, Lung and Blood Institute, a division of the National Institutes of Health (NIH), the LGRC project consists of five institutions, including Dana-Farber Cancer Institute. Collaborators in the project work with samples banked at the Lung Tissue Research Consortium (LTRC), which houses tissue samples and blood from lung disease sufferers, primarily chronic obstructive pulmonary disease (COPD), along with a rich set of clinical data from patients.

About Conference

Hear, Explore and learn the latest research. Present before distinguished global audience. Collaborate, build partnerships and experience Japan. Join the global academic community.

ConferenceSeries Ltd invites all the participants across the globe to attend the 10th World Congress on Stem Cell and Biobanking October 23-24, 2017 Osaka, Japan. Stem Cell Convention 2017 includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Stem Cell Convention 2017 aims in proclaim knowledge and share new ideas amongst the professionals, industrialists and students from research area of Stem Cell and Biobanking to share their research experiences and indulge in interactive discussions at the event. This scientific gathering guarantees that offering the thoughts and ideas will enable and secure you the theme “Accelerating Innovative Research &Technology in Stem Cell & Biobanking”. Stem Cell and Biobanking is the latest trending research in many fields especially in Organ cancer: breast, oral, head and neck Cancer Myeloid, lymphoid leukaemia’s, cancer treatments etc. The current era fully rolled out with many new advanced treatment technologies. In such case more Stem Cells research institutes were newly introduced within market which obviously shows the market growth of Stem Cells and Biobanking. While analysing the revenue growth of Stem Cells and Biobanking functions, it highly developed from $150 billion USD to $250 billion USD since from 2010-2015. And the annual growth percentage increases from 20-55 percentages.

Importance and Scope:

Recently, there has been an increasing demand for quality and trained manpower in this evolving branch of biomedicine. As a result of this, stem cells research is emerging as a rage among the many career options available to people in associated fields. The current investment in stem cell research in India is more than 1000 crores. Most of the investment in stem cell research in India is in the government sector. So there are a lot of research opportunities on a national front in India.

Why to attend?

With members from around the world focused on learning about Stem Cells and Biobanking, this is your single best opportunity to reach the largest assemblage of participants from the Stem cells research community. Conduct demonstrations, distribute information, acquire knowledge about current and trending Stem cells and Biobanking technologies, make a splash with a new research, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in fields are hallmarks of this conference.

Target Audience:

Head of the Departments from the field of Biological sciences, Genetics, Regenerative medicine, Oncology…

Doctors from the fields of Oncology, surgery, organ transplantation, infertility, Clinical Trails

Stem cell and Biobanking Lab Directors/Associates

Stem cell researchers and academicians

Doctorates in Bio- Sciences

Professors and Students from Academia in the study of Stem cell and Biobanking research

Regenerative medicine Lab Directors/Associates

Professors of Life sciences

Conference Highlights

Stem Cells
Stem Cell Therapy

Stem Cell Apoptosis and Signal Transduction
Stem Cell Transplantation
Cell Signalling in Development
Epigenetics
Stem Cell Embryology
Stem Cell Niches
Stem cell treatment
Stem Cells Biology
Stem Cells Technology
Stem cell Bioinformatics
Bio-banks
Stem cells Biomarkers
Cells & Organ Regeneration
Biorepository & Biospecimen
Fertility bio banks
Bio bank Ethics
Next Generation Biobanking

Special Issues:

All accepted abstracts will be published in respective International Journals.

Abstracts will be provided with Digital Object Identifier by Cross Ref.

See more at: http://stemcell.conferenceseries.com/asiapacific/

Market Analysis

10th World Congress on Stem Cell and Biobanking

Success of the 9th Cell Science conferences series has given us the prospect to bring the gathering one more time for our 10^th World Congress on Stem Cell and Biobanking 2017 meet in October 23-24, 2017 Osaka, Japan. Since its commencement in 2011 cell science series has perceived around 750 researchers of great potentials and outstanding research presentations around the globe. The awareness of stem cells and its application is increasing among the general population that also in parallel offers hope and add woes to the researchers of cell science due to the potential limitations experienced in the real-time.

Stem Cell Convention 2017 has the goal to fill the prevailing gaps in the transformation of this science of hope to promptly serve solutions to all in the need. Stem cells Convention 2017 will have an anticipated participation of 100-120 delegates from around the world to discuss the conference goal.

History of Stem cells Research

Stem cells have an interesting history; in the mid 1800s it was revealed that cells were basically the building blocks of life and that some cells had the ability to produce other cells. Efforts were made to fertilize mammalian eggs outside of the human body and in the early 1900s, it was discovered that some cells had the capacity to generate blood cells. In 1968, the first bone marrow transplant was achieved successfully to treat two siblings with severe combined immunodeficiency. Other significant events in stem cell research include:

1978: Stem cells were discovered in human cord blood
1981: First in vitro stem cells line developed from mice
1988: Embryonic stem cells lines created from a hamster
1995: First embryonic stem cells line derived from a primate
1997: Cloned lamb from stem cells
1997: Leukemia origin found as haematopoietic stem cells, indicating possible proof of cancer stem cells

Funding in USA:

No federal law forever did embargo stem cells research in the United States, but only placed restrictions on funding and use, under Congress's power to spend. By executive order on March 9, 2009, President Barack Obama removed certain restrictions on federal funding for research involving new lines of human embryonic stem cells. Prior to President Obama's executive order, federal funding was limited to non-embryonic stem cells research and embryonic stem cells research based upon embryonic stem cells lines in existence prior to August 9, 2001. In 2011, a United States District Court "threw out a lawsuit that challenged the use of federal funds for embryonic stem cell research”.

Members Associated with Stem Cells Research:

Discussion on Development, Regeneration, and Stem Cells Biology takes an interdisciplinary approach to understanding the fundamental question of how a single cells, the fertilized egg, ultimately produces a complex fully patterned adult organism, as well as the intimately related question of how adult structures regenerate. Stem cells play critical roles both during embryonic development and in later renewal and repair. More than 65 faculties in Philadelphia from both basic science and clinical departments in the Division of Biological Sciences belong to Development, Regeneration, and Stem Cells Biology. Their research uses traditional model species including nematode worms, fruit-flies, Arabidopsis, zebrafish, amphibians, chick and mouse as well as non-traditional model systems such as lampreys and cephalopods. Areas of research focus include stem cell biology, regeneration, developmental genetics, and cellular basis of development, developmental neurobiology, and “evo-devo” (Evolutionary developmental biology).

Stem Cell Market Value:

Worldwide many companies are developing and marketing specialized cells culture media, cells separation products, instruments and other reagents for life sciences research. We are providing a unique platform for the discussions between academia and business.

Global Tissue Engineering & Stem Cell Therapy Market, By Region, 2009 2018

$Million

Why to attend???

Stem Cell Research-2017 could be an outstanding event that brings along a novel and International mixture of researchers, doctors, leading universities and stem cell analysis establishments creating the conference an ideal platform to share knowledge, adoptive collaborations across trade and world, and assess rising technologies across the world. World-renowned speakers, the most recent techniques, tactics, and the newest updates in cell science fields are assurances of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://stemcell.omicsgroup.com/sponsors.php

UAS Major Universities which deals with Stem Cell Research

· University of Washington/Hutchinson Cancer Center

· Oregon Stem Cell Center

· University of California Davis

· University of California San Francisco

· University of California Berkeley

· Stanford University

· Mayo Clinic

Major Stem Cell Organization Worldwide:

· Norwegian Center for Stem Cell Research

· France I-stem

· Stem Cell & Regenerative Medicine Ctr, Beijing

· Stem Cell Research Centre, Korea

· NSW Stem Cell Network

· Monash University of Stem Cell Labs

· Australian Stem Cell Centre

Target Audience:

Eminent personalities, Directors, CEO, President, Vice-president, Organizations, Associations heads and Professors, Research scientists, Stem Cell laboratory heads, Post-docs, Students other affiliates related to the area of Stem cell research, stem cell line companies can be as Target Audience

Market Analysis of Stem Cell Therapy:

The global market for stem cell products was $3.8 billion in 2011. This market is expected to reach nearly $4.3 billion in 2012 and $6.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 11.7% from 2011 to 2016.

Americas is the largest region of global stem cells market, with a market share of about $2.0 billion in 2013. The region is projected to increase to nearly $3.9 billion by 2018, with a CAGR of 13.9% for the period of 2013 to 2018

Europe is the second largest segment of the global stem cell market and is expected to grow at a CAGR of 13.4% reaching about $2.4 billion by 2018 from nearly $1.4 billion in 2013.

Figure 2: Global Market

Companies working for Stem Cell:

Company	Location	Business Type
Cynata Therapeutics	Armadale, Australia	Stem Cell Manufacturing Technology
Mesoblast	Melbourne, Australia	Regenerative Medicine
Activartis	Vienna, Austria	Dendritic Cell-Based Cancer Immunotherapy
Aposcience	Vienna, Austria	Treatments composed of mixture of cytokines, growth factors and other active components
Cardio3 Biosciences	Mont-Saint-Guibert, Belgium	Stem Cell Differentiation
Orthocyte (BioTime)	Alameda, CA	Cellular Therapies
Capricor	Beverly Hills, CA	Stem Cell Heart Treatments
Life Stem Genetics	Beverly Hills, CA	Autologous stem cell therapy
International Stem Cell	Carlsbad, CA	Proprietary Stem Cell Induction
Targazyme	Carlsbad, CA	Cell Therapy
DaVinci Biosciences	Costa Mesa, CA	Cellular Therapies
Invitrx Therapeutics	Irvine, CA	Autologous Stem Cell Therapy, Therapeutic & Cosmetic

Stem Cell Software’s :

Cryus : Cryus is developed specially for Cord Blood Banks, Donor Centers, Stem Cells Collection Centers, Biotech Laboratories and Tissue Banks.
Label-InnThe: Which allows to record the donor or the patient personal data into the database and generates the Donation Identification Number (DIN) according to ICCBBA international standard ISBT128. It serves as labelling software for blood samples and Stem Cells products.

Products Manufactured By Industry Related to Stem Cell:

RoboSep™-16 is the latest RoboSep™ instrument ingenuous for performing fully-automated cell separation from a huge number of samples. Using EasySep™, the column-free immunomagnetic cell separation system, RoboSep™-16 isolates desired cells from a wide range of samples from different species, tissue sources or sizes using positive or negative selection. Through an intuitive user interface, the RoboSep™-16 simultaneously isolates cells from up to sixteen samples with minimal hands on time. By automating all reagent and sample handling steps, and through the use of disposable pipette tips, the RoboSep™-16 rapidly isolates all desired cells while minimizing the risk of sample cross-contamination. After completion of the cell isolation procedure, cells of interest are immediately available for any downstream application.

The EasySep™ Mouse CD25 Regulatory T Cell Positive Selection Kit is designed to isolate highly purified CD25+ cells from single cell suspensions of splenocytes or other tissues by positive selection. Desired cells are labeled with antibodies and magnetic particles. The cells are separated without columns using an EasySep™ magnet. Unwanted cells are simply poured off, while desired cells remain in the tube. Isolated cells are immediately ready for downstream applications such as flow cytometry, cell culture, or suppression assays.

Featured Research:

Gene therapy gives assurance for severe combined immunodeficiency, Researchers have initiated that gene therapy using a improved delivery system, or vector, can restore the immune systems of children with X-linked severe combined immunodeficiency (SCID-X1), a rare, life-threatening inherited condition that primarily affects boys. Previous efforts to treat SCID-X1 with gene therapy were initially efficacious, but approximately one-quarter of the children developed leukemia two to five years after treatment. Results from a study partially funded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), suggest that the new vector is equally effective at restoring immunity and may be safer than previous approaches.

References:

http://www.stemcell.com/en/Products/All-Products/EasySep-Mouse-CD25-Regulatory-T-Cell-Positive-Selection-Kit.aspx

http://www.stemcell.com/en/Products/All-Products/EasySep-Mouse-CD25-Regulatory-T-Cell-Positive-Selection-Kit.aspx
http://seekingalpha.com/article/1347281-investing-in-the-stem-cell-sector-an-overview
http://mbbnet.umn.edu/scmap/scresearchmap.html
http://biopharmguy.com/links/company-by-location-stem-cells.php
http://www.marketwired.com/press-release/latest-research-shows-stem-cell-product-market-to-reach-6-billion-by-2016-1688406.htm

Past Conference Report

Stem Cell Congress 2016 Report

7^th Annual Conference on Stem Cell and Regenerative Medicine was organized during August 04-05, 2016 at Manchester, UK. The conference was marked with the attendance of Editorial Board Members of supporting journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive.

This conference was based on the theme “Advanced Approaches In Stem Cell and Regenerative Medicine”

The Organizing Committee would like to thank the moderator Dr. Nilanjana Maulik (University of Connecticut, USA) for her contribution which resulted in smooth functioning of the conference.

The conference proceeded through various scientific sessions and plenary lectures, of which the following topics were highlighted as Keynote presentations:

Barritault Denis - The importance of extra cellular matrix organization and the use of RGTA technology in regenerative Medicine(OTR3, France)

Y James Kang -Rejuvenation therapy for ischemic heart disease(Sichuan University, China)

Taihua Wang- Significant physical function improvements of 3 serious injured patients after neural stem cell therapy (Interventional Hospital of Shandong Red Cross Society and Cell Biotechnology Co. Ltd, China)

Gang Zhang- Using ‘Mouse Clone Model’ to open the door for human iPSC therapy (Interventional Hospital of Shandong Red Cross Society and Cell Biotechnology Co. Ltd, China)

Pedro Morouço - A novel regenerative medicine approach to reconstruct the temporomandibular joint disk (Centro Empresarial da Marinha Grande, Portugal)

Various sessions were chaired and co-chaired by: Barritault Denis-OTR3, France; Hazem Barmada- Mississippi Stem cell Treatment Center, USA;Serban San-Marina- Mayo Clinic, USA; Raphael Gorodetsky- Hadassah-Hebrew University Medical Center, Israel

Conference Series has taken the privilege of felicitating Stem Cell Congress -2016 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this conference.

The esteemed guests, keynote speakers and researchers shared their innovative research and vast experience through their informative presentations at the podium of Stem Cell Congress-2016. We are glad to inform that all accepted abstracts for the conference have been published in Journal of Stem Cell Research & Therapy: Open Access as a special issue.

We are also obliged to various experts, company representatives and other eminent scientists who supported the conference by facilitating the discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique feedback from the conference, Conference Series would like to proudly announce the commencement of the " 9th Annual Conference on Stem Cell and Regenerative Medicine" to be organized during Sep 05-06, 2017 at Paris, France.

Mark your calendars for the upcoming Conference; we are hoping to see you soon at Stem Cell and Bio-Banking 2017, Osaka, Japan.

To Collaborate Scientific Professionals around the World

Conference Date October 23-24, 2017

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Past Conference Report

Stem Cell Congress 2016 Report Stem Cell Congress 2016 Gallery Stem Cell Congress 2016 Proceedings Stem Cell Congress 2016 Conference

Supported By

Journal of Stem Cell Research & Therapy Cell & Developmental Biology Journal of Cell Science & Therapy Journal of Fertilization: In Vitro - IVF-Worldwide, Reproductive Medicine, Genetics & Stem Cell Biol

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

Stem Cell and Biobanking

October 23-24, 2017 Osaka, Japan

â€œAccelerating Innovative Research & Technology in Stem Cell & Bio banking.â€

Stem Cell Congress | Biobanking Conferences | Regenerative Medicine Conferences | Stem Cell & Cancer Conferences | CME Conferences | Worldwide Events | Osaka | Japan | Asia Pacific | 2017 | Conference Series LLC LTD

Conference Series Conferences gaining more Readers and Visitors

Previous Speakers

Raphael Gorodetsky

Taihua Wang

Y James Kang

Pierre-Edouard Dolle

Prabhu Mishra

Aditya Borakati

Gang Zhang

Naglaa Kamal Idriss

Recommended Global Genetics & Molecular Biology Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Stem Cell Convention-2017

Sessions/Tracks

About Conference

Market Analysis

Past Conference Report

To Collaborate Scientific Professionals around the World

Useful Links

Past Conference Report

Supported By